Walleye Trading’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-839
| Closed | -$126K | – | 4322 |
|
|
2026
Q1 | $128K | Buy |
+839
| New | +$129K | ﹤0.01% | 3342 |
|
|
2025
Q4 | – | Sell |
-9,181
| Closed | -$1.2M | – | 4706 |
|
|
2025
Q3 | $1.18M | Buy |
+9,181
| New | +$1.12M | ﹤0.01% | 2157 |
|
|
2025
Q2 | – | Sell |
-18,026
| Closed | -$2.03M | – | 4573 |
|
|
2025
Q1 | $2.01M | Sell |
18,026
-4,989
| -22% | -$531K | ﹤0.01% | 1631 |
|
|
2024
Q4 | $2.24M | Buy |
23,015
+22,399
| +3,636% | +$2.39M | ﹤0.01% | 1623 |
|
|
2024
Q3 | $70.9K | Sell |
616
-757
| -55% | -$85.9K | ﹤0.01% | 3427 |
|
|
2024
Q2 | $146K | Sell |
1,373
-8,765
| -86% | -$880K | ﹤0.01% | 3227 |
|
|
2024
Q1 | $981K | Sell |
10,138
-28,715
| -74% | -$2.94M | ﹤0.01% | 2264 |
|
|
2023
Q4 | $3.92M | Sell |
38,853
-8,569
| -18% | -$827K | 0.01% | 1398 |
|
|
2023
Q3 | $4.83M | Buy |
+47,422
| New | +$4.81M | 0.01% | 1151 |
|
|
2020
Q2 | – | Sell |
-8,444
| Closed | -$729K | – | 4492 |
|
|
2020
Q1 | $696K | Buy |
+8,444
| New | +$753K | 0.01% | 1585 |
|
|
2018
Q4 | – | Sell |
-10,074
| Closed | -$784K | – | 5097 |
|
|
2018
Q3 | $778K | Buy |
10,074
+1,351
| +15% | +$99.9K | ﹤0.01% | 2377 |
|
|
2018
Q2 | $590K | Buy |
8,723
+1,997
| +30% | +$138K | ﹤0.01% | 2671 |
|
|
2018
Q1 | $487K | Buy |
+6,726
| New | +$512K | ﹤0.01% | 2676 |
|
|
2017
Q4 | – | Sell |
-10,537
| Closed | -$795K | – | 4549 |
|
|
2017
Q3 | $811K | Buy |
+10,537
| New | +$796K | ﹤0.01% | 2061 |
|
|
2017
Q2 | – | Sell |
-49,354
| Closed | -$3.5M | – | 4814 |
|
|
2017
Q1 | $3.29M | Buy |
+49,354
| New | +$3.29M | 0.02% | 724 |
|
|
2016
Q4 | – | Sell |
-5,199
| Closed | -$337K | – | 5036 |
|
|
2016
Q3 | $368K | Buy |
+5,199
| New | +$379K | ﹤0.01% | 2376 |
|
|
2016
Q2 | – | Sell |
-4,501
| Closed | -$311K | – | 5610 |
|
|
2016
Q1 | $292K | Sell |
4,501
-25,837
| -85% | -$1.76M | ﹤0.01% | 2436 |
|
|
2015
Q4 | $2.34M | Buy |
30,338
+20,436
| +206% | +$1.62M | 0.02% | 679 |
|
|
2015
Q3 | $816K | Buy |
9,902
+8,543
| +629% | +$760K | 0.01% | 1213 |
|
|
2015
Q2 | $120K | Sell |
1,359
-11,443
| -89% | -$1.05M | ﹤0.01% | 2892 |
|
|
2015
Q1 | $1.13M | Buy |
+12,802
| New | +$1.14M | 0.01% | 947 |
|
Other funds holding NVS
Walleye Trading's NVS Position: Q2 2026 in Review
Walleye Trading sold out of Novartis (NVS) in Q2 2026, closing a stake of 839 shares — an estimated $126K sold.
Walleye Trading first reported a position in NVS in Q1 2015 and held it in 21 quarters. The position peaked at $4.83M in Q3 2023. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Walleye Trading reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
- Walleye Trading sold 839 Novartis shares in Q2 2026, an estimated $126K.
- Walleye Trading first reported a position in Novartis in Q1 2015 and held it in 21 quarters.
- Walleye Trading's Novartis position peaked at $4.83M in Q3 2023.
- 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.